Article
Modelling the role of dual specificity phosphatases in Herceptin resistant breast cancer cell lines
2019-01-23
Abstract excerpt
<h4>Background</h4> Breast cancer remains the most lethal type of cancer for women. A significant proportion of breast cancer cases are characterised by overexpression of the human epidermal growth factor receptor 2 protein (HER2). These cancers are commonly treated by Herceptin (Trastuzumab), but resistance to drug treatment frequently develops in tumour cells. Dual-specificity phosphatases (DUSPs) are thought t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e1352913-a9df-5bb5-a202-0f1c3fe01fc8
- DOI
- 10.1101/528315
